FDA NDC Directory · JSON-LD · Markdown

Orenitram

NDC 66302-302 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE

Generic nametreprostinil
Labeler / ManufacturerUnited Therapeutics Corporation
Marketing categoryNew Drug Application (innovator) · App NDA203496
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsTREPROSTINIL (.25 mg/1)
Marketing started20131220
Package count2

External sources

Source: openFDA. Public-domain (CC0).